SCHEMBL7270435

SCHEMBL7270435

CC(C)[C@H](N)C(=O)N(C(=O)NCc1cccnc1)C(Cc1ccccc1)C(O)C(Cc1ccccc1)N(C(=O)NCc1cccnc1)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 3/20 0.46
RECQL P46063 1/20 0.45
HTT P42858 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
NAMPT P43490 2/20 0.42
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269984 0.89 ALDH1A1 (0.41) L3MBTL1CYP3A4KMT2AALDH1A1
SCHEMBL7270433 0.84 TSHR (0.56) L3MBTL1HPGDSMN1; SMN2CYP1A2KMT2A
SCHEMBL7268678 0.84 CTSD (0.55) CYP1A2CYP3A4CYP2C19
SCHEMBL7269049 0.82 LMNA (0.47) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9740522 0.82 LMNA (0.48) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7268965 0.82 CYP3A4 (0.46) LMNACYP3A4KMT2ANAMPT
SCHEMBL6447519 0.82 LMNA (0.48) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9741503 0.81 LMNA (0.47) LMNACYP3A4KMT2ANAMPT
SCHEMBL6449476 0.81 LMNA (0.47) LMNACYP3A4KMT2ANAMPT
SCHEMBL6446316 0.81 LMNA (0.47) LMNACYP3A4KMT2ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed